TT12
/ Tessa Therap
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
November 29, 2025
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
(clinicaltrials.gov)
- P1 | N=32 | Active, not recruiting | Sponsor: Baylor College of Medicine | Trial primary completion date: Oct 2025 ➔ Jan 2026
Trial primary completion date • Anal Carcinoma • Cervical Cancer • Genito-urinary Cancer • Gynecologic Cancers • Oncology • Oropharyngeal Cancer • Penile Cancer • Solid Tumor • Vulvar Cancer
December 04, 2024
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
(clinicaltrials.gov)
- P1 | N=32 | Active, not recruiting | Sponsor: Baylor College of Medicine | Trial primary completion date: Oct 2024 ➔ Oct 2025
Trial primary completion date • Anal Carcinoma • Cervical Cancer • Genito-urinary Cancer • Gynecologic Cancers • Oncology • Oropharyngeal Cancer • Penile Cancer • Solid Tumor • Vulvar Cancer
December 20, 2023
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
(clinicaltrials.gov)
- P1 | N=32 | Active, not recruiting | Sponsor: Baylor College of Medicine | Trial primary completion date: Oct 2023 ➔ Oct 2024
Trial primary completion date • Anal Carcinoma • Cervical Cancer • Gastrointestinal Cancer • Genito-urinary Cancer • Gynecologic Cancers • Oncology • Oropharyngeal Cancer • Penile Cancer • Solid Tumor • Vulvar Cancer
December 28, 2022
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
(clinicaltrials.gov)
- P1 | N=32 | Active, not recruiting | Sponsor: Baylor College of Medicine | Trial primary completion date: Oct 2022 ➔ Oct 2023
Trial primary completion date • Anal Carcinoma • Cervical Cancer • Gastrointestinal Cancer • Genito-urinary Cancer • Gynecologic Cancers • Oncology • Oropharyngeal Cancer • Penile Cancer • Solid Tumor • Vulvar Cancer
January 11, 2022
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
(clinicaltrials.gov)
- P1; N=32; Active, not recruiting; Sponsor: Baylor College of Medicine; Recruiting ➔ Active, not recruiting; Trial primary completion date: Oct 2021 ➔ Oct 2022
Clinical • Enrollment closed • Trial primary completion date • Anal Carcinoma • Cervical Cancer • Gastrointestinal Cancer • Genito-urinary Cancer • Gynecologic Cancers • Oncology • Oropharyngeal Cancer • Penile Cancer • Solid Tumor • Vulvar Cancer
1 to 5
Of
5
Go to page
1